Detalles de la búsqueda
1.
Amantadine as adjuvant therapy in the treatment of moderate to severe obsessive-compulsive disorder: A double-blind randomized trial with placebo control.
Psychiatry Clin Neurosci
; 73(4): 169-174, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30488617
2.
Waterpipe and cigarette smoking and drug and alcohol consumption, and the risk of primary progressive multiple sclerosis: A population-based case-control study.
Curr J Neurol
; 22(2): 72-81, 2023 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38011368
3.
Ketamine and Other Glutamate Receptor Modulating Agents for Treatment-Resistant Depression: A Systematic Review of Randomized Controlled Trials.
Iran J Psychiatry
; 17(3): 320-340, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36474699
4.
Environmental risk factors of multiple sclerosis in the Middle East and North Africa region: A systematic review.
Curr J Neurol
; 20(3): 166-184, 2021 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38011462
5.
L-Carnosine combination therapy for major depressive disorder: A randomized, double-blind, placebo-controlled trial.
J Affect Disord
; 267: 131-136, 2020 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32063564
6.
5-Hydroxytryptophan as adjuvant therapy in treatment of moderate to severe obsessive-compulsive disorder: a double-blind randomized trial with placebo control.
Int Clin Psychopharmacol
; 35(5): 254-262, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32541380
7.
Crocus sativus L. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study.
J Child Adolesc Psychopharmacol
; 29(3): 205-212, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30741567
Resultados
1 -
7
de 7
1
Próxima >
>>